FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...

If left untreated, the disease can lead to severe, long-term symptoms, and life-threatening issues like heart failure, ...